182 related articles for article (PubMed ID: 27035620)
1. Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer.
Hornsveld M; Tenhagen M; van de Ven RA; Smits AM; van Triest MH; van Amersfoort M; Kloet DE; Dansen TB; Burgering BM; Derksen PW
Cell Death Differ; 2016 Sep; 23(9):1483-92. PubMed ID: 27035620
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase.
Kang HG; Jenabi JM; Zhang J; Keshelava N; Shimada H; May WA; Ng T; Reynolds CP; Triche TJ; Sorensen PH
Cancer Res; 2007 Apr; 67(7):3094-105. PubMed ID: 17409416
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.
Luey BC; May FE
Mol Cancer; 2016 Jan; 15():8. PubMed ID: 26801096
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor inhibits anoikis of pancreatic carcinoma cells through phosphatidylinositol 3-kinase pathway.
Watanabe S; Kishimoto T; Yokosuka O
Pancreas; 2011 May; 40(4):608-14. PubMed ID: 21499215
[TBL] [Abstract][Full Text] [Related]
5. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS
Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907
[TBL] [Abstract][Full Text] [Related]
6. Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF).
Tan BS; Tiong KH; Choo HL; Chung FF; Hii LW; Tan SH; Yap IK; Pani S; Khor NT; Wong SF; Rosli R; Cheong SK; Leong CO
Cell Death Dis; 2015 Jul; 6(7):e1826. PubMed ID: 26181206
[TBL] [Abstract][Full Text] [Related]
7. Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis.
Schmelzle T; Mailleux AA; Overholtzer M; Carroll JS; Solimini NL; Lightcap ES; Veiby OP; Brugge JS
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3787-92. PubMed ID: 17360431
[TBL] [Abstract][Full Text] [Related]
8. ERalpha signaling through slug regulates E-cadherin and EMT.
Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
[TBL] [Abstract][Full Text] [Related]
9. Loss of T-cadherin (CDH-13) regulates AKT signaling and desensitizes cells to apoptosis in melanoma.
Bosserhoff AK; Ellmann L; Quast AS; Eberle J; Boyle GM; Kuphal S
Mol Carcinog; 2014 Aug; 53(8):635-47. PubMed ID: 23625515
[TBL] [Abstract][Full Text] [Related]
10. HCRP-1 regulates EGFR-AKT-BIM-mediated anoikis resistance and serves as a prognostic marker in human colon cancer.
Chen F; Zhang L; Wu J; Huo F; Ren X; Zheng J; Pei D
Cell Death Dis; 2018 Dec; 9(12):1176. PubMed ID: 30518879
[TBL] [Abstract][Full Text] [Related]
11. Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells.
Kochetkova M; Kumar S; McColl SR
Cell Death Differ; 2009 May; 16(5):664-73. PubMed ID: 19136936
[TBL] [Abstract][Full Text] [Related]
12. HAb18G/CD147 cell-cell contacts confer resistance of a HEK293 subpopulation to anoikis in an E-cadherin-dependent manner.
Ma XK; Wang L; Li Y; Yang XM; Zhao P; HaoTang ; Zhu P; Li L; Chen ZN
BMC Cell Biol; 2010 Apr; 11():27. PubMed ID: 20398401
[TBL] [Abstract][Full Text] [Related]
13. Re-inforcing the cell death army in the fight against breast cancer.
Oudenaarden CRL; van de Ven RAH; Derksen PWB
J Cell Sci; 2018 Aug; 131(16):. PubMed ID: 30139926
[TBL] [Abstract][Full Text] [Related]
14. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
[TBL] [Abstract][Full Text] [Related]
15. miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling.
Chen Y; Sun Y; Chen L; Xu X; Zhang X; Wang B; Min L; Liu W
Mol Med Rep; 2013 May; 7(5):1579-84. PubMed ID: 23546450
[TBL] [Abstract][Full Text] [Related]
16. PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer.
Barber AG; Castillo-Martin M; Bonal DM; Jia AJ; Rybicki BA; Christiano AM; Cordon-Cardo C
Cancer Med; 2015 Aug; 4(8):1258-71. PubMed ID: 26033689
[TBL] [Abstract][Full Text] [Related]
17. The attenuation of epithelial to mesenchymal transition and induction of anoikis by gigantol in human lung cancer H460 cells.
Unahabhokha T; Chanvorachote P; Pongrakhananon V
Tumour Biol; 2016 Jul; 37(7):8633-41. PubMed ID: 26733180
[TBL] [Abstract][Full Text] [Related]
18. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
19. Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification.
Tanizaki J; Okamoto I; Fumita S; Okamoto W; Nishio K; Nakagawa K
Oncogene; 2011 Sep; 30(39):4097-106. PubMed ID: 21499301
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancer.
Teo K; Gómez-Cuadrado L; Tenhagen M; Byron A; Rätze M; van Amersfoort M; Renes J; Strengman E; Mandoli A; Singh AA; Martens JH; Stunnenberg HG; van Diest PJ; Brunton VG; Derksen PWB
Sci Rep; 2018 Oct; 8(1):15454. PubMed ID: 30337563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
